Loading clinical trials...
Loading clinical trials...
The primary objective of this research study is to improve outcomes involving core social-communication symptoms for young children with ASD or social communication delays by increasing access to clin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Collaborators
NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders
NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more
NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more
NCT07524192 · Autism Spectrum Disorder, Developmental Disabilities, and more
NCT06158581 · Autism Spectrum Disorder
Kennedy Krieger Institute
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions